Cargando…

Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer

In the present study, we successfully developed a docetaxel (DTX) and thalidomide (TDD) co-delivery system based on low density lipoprotein (LDL) modified silica nanoparticles (LDL/SLN/DTX/TDD). By employing the tumor homing property of LDL and the drug-loading capability of silica nanoparticles, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ao, Man, Xiao, Xu, Ao, Yazhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912100/ https://www.ncbi.nlm.nih.gov/pubmed/29513882 http://dx.doi.org/10.1590/1414-431X20176650

Ejemplares similares

Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010)

Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity
por: Xue, Hantao, et al.
Publicado: (2021)

N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors
por: Zhang, Chun-ge, et al.
Publicado: (2014)

Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma
por: Ye, Junfeng, et al.
Publicado: (2018)

Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy
por: Gong, Miaomiao, et al.
Publicado: (2019)

“Three-Bullets” Loaded Mesoporous Silica Nanoparticles for Combined Photo/Chemotherapy †
por: Tessaro, André Luiz, et al.
Publicado: (2019)

The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review
por: Chen, Long, et al.
Publicado: (2014)

Lipid composition of circulating multiple-modified low density lipoprotein
por: Zakiev, E. R., et al.
Publicado: (2016)

Carbohydrate composition of circulating multiple-modified low-density lipoprotein
por: Zakiev, Emile R, et al.
Publicado: (2016)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
por: Oh, Keun Sang, et al.
Publicado: (2016)

Indocyanine Green Loaded Modified Mesoporous Silica Nanoparticles as an Effective Photothermal Nanoplatform
por: Wang, Yiyu, et al.
Publicado: (2020)

A modified formula for calculating low-density lipoprotein cholesterol values
por: Chen, Yunqin, et al.
Publicado: (2010)

Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
por: Delporte, Cédric, et al.
Publicado: (2013)

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017)

Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro
por: Vivero-Escoto, Juan L., et al.
Publicado: (2015)

Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel
por: Khosravian, Pegah, et al.
Publicado: (2016)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)

Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
por: Jurczyk, Magdalena, et al.
Publicado: (2022)

Efficacy and Safety of Thalidomide for Chemotherapy-induced Nausea and Vomiting
por: Wang, Nan, et al.
Publicado: (2020)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease
por: Cimen, Fuat, et al.
Publicado: (2012)

Nanoparticles with High-Surface Negative-Charge Density Disturb the Metabolism of Low-Density Lipoprotein in Cells
por: Bai, Xue, et al.
Publicado: (2018)

Possible Regulation of Platelets by Native and Modified Low Density Lipoprotein-Cholesterol Particles
por: Han, Ki Hoon
Publicado: (2012)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System
por: Burchill, Matthew A., et al.
Publicado: (2020)

Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients
por: Shen, Hao, et al.
Publicado: (2016)

Glucose-Modified Zein Nanoparticles Enhance Oral Delivery of Docetaxel
por: Xing, Yabing, et al.
Publicado: (2022)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer
por: Zhang, Xiaoxue, et al.
Publicado: (2019)

Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin Nanoparticles
por: Niknejad, Hassan, et al.
Publicado: (2015)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells
Publicado: (1985)

Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines
por: Resch, Ulrike, et al.
Publicado: (2011)

Preliminary Analysis of Modified Low-Density Lipoproteins in the Serum of Healthy and Obese Dogs and Cats
por: Mori, Nobuko, et al.
Publicado: (2015)

Palmitate and minimally-modified low-density lipoprotein cooperatively promote inflammatory responses in macrophages
por: Ann, Soo-jin, et al.
Publicado: (2018)

Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases
por: Obama, Takashi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d5v5cjtau9rthfc7tdnotm3iso